Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frontier-1: KH902 in Diabetic Macular Edema
NCT01324869Phase 2Completed
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Apr 2010
- Primary completion
- Feb 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in diabetic macular edema (DME), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Started Apr 2010; status: completed.
02
Drugs
conbercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01324869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324869.